Skip to main content
Adam Burgoyne, MD, Oncology, La Jolla, CA

AdamBurgoyneMDPhD(He/Him)

Oncology • La Jolla, CA

Gastrointestinal Cancer

Assistant Clinical Professor

Join to view full profile

Dr. Burgoyne is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Burgoyne's full profile

Already have an account?

Summary

  • Adam Burgoyne, MD, PhD, is a medical oncologist with research and clinical interests in gastrointestinal and hepatobiliary oncology at UC San Diego. His clinical practice at the Moores Cancer Center is primarily dedicated to the care of patients with hepatocellular carcinoma (HCC), where he co-leads a multidisciplinary primary liver cancer clinic and serves as the principal investigator of both sponsored and investigator-initiated clinical trials for patients with advanced liver cancer. As an academic physician-scientist, he also runs a basic and translational science laboratory working on the development and validation of a cellular state prediction model of sensitivity and resistance to targeted therapies in HCC. Dr. Burgoyne earned his medical degree and doctorate from Case Western Reserve University School of Medicine in Cleveland, Ohio. He completed his residency in internal medicine, fellowship in hematology/oncology, and post-doctoral research training at UC San Diego. He joined the faculty within the Division of Hematology/Oncology at UC San Diego in February 2017, where he is currently an Assistant Clinical Professor.

Education & Training

  • University of California (San Diego) Medical Center
    University of California (San Diego) Medical CenterFellowship, Hematology and Medical Oncology, 2013 - 2016
  • University of California (San Diego) Medical Center
    University of California (San Diego) Medical CenterResidency, Internal Medicine, 2011 - 2013
  • Case Western Reserve University School of Medicine
    Case Western Reserve University School of MedicineClass of 2011

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2012 - 2024
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Inductee Alpha Omega Alpha Honor Medical Society, 2011

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Tumor Symbiosis: Gastrointestinal Stromal Tumor as a Host for Primary Peritoneal Mesothelioma  
    Sudeep Banerjee, Adam M Burgoyne, Joel Baumgartner, Amanda Kirane, Grace Y Lin, Jason Sicklick, Journal of gastrointestinal surgery

Press Mentions

  • A Common Plant Takes on a Rare Cancer
    A Common Plant Takes on a Rare CancerFebruary 5th, 2021
  • Temozolomide (TMZ) in Advanced Succinate Dehydrogenase (SDH)-Mutant/Deficient Gastrointestinal Stromal Tumor (GIST)
    Temozolomide (TMZ) in Advanced Succinate Dehydrogenase (SDH)-Mutant/Deficient Gastrointestinal Stromal Tumor (GIST)June 14th, 2018
  • GIST Tumors Linked to NF1 Mutations, Genetic Testing Needed
    GIST Tumors Linked to NF1 Mutations, Genetic Testing NeededAugust 18th, 2017

Professional Memberships

Dr. Adam Burgoyne, Dr. Adam Burgoyne, MD, Dr. A Burgoyne